Literature DB >> 16530959

Genetic analysis of the GABRA1 gene in patients with essential tremor.

Hao Deng1, Wen-Jie Xie, Wei-Dong Le, Mao-Sheng Huang, Joseph Jankovic.   

Abstract

The gamma-aminobutyric acid A (GABA-A) receptor mediates inhibitory neurotransmission in the brain and as such may be involved in certain neurological movement disorders, such as tremor. GABA-A receptor alpha 1 (Gabra)(-/-) mice have been reported to exhibit postural and kinetic, alcohol-responsive, tremor that is characteristic of essential tremor (ET), the most common form of tremor. To determine whether ET is associated with the GABRA1 gene mutation, we screened 76 patients with familial ET and found a novel nucleotide variant: IVS8+24 G>T (nt 6119289) in a male patient, and a known 156T>C polymorphism (nt 6090903) in exon 4 in 41% patients, which results in a silent mutation (G52G). No significant association between 156T>C variant and disease risk was found (adjusted OR=0.95, 95% CI=0.57-1.61; p=0.858) by further analysis of 121 familial ET patients and 114 normal controls, except a novel 96A>G (Q32Q; nt 6090743) variant, found in a normal control. Since the 156T>C variant appears to be not pathogenically relevant, our results suggest that missense, nonsense or splice site mutation in the coding region of the GABRA1 gene is not a major genetic cause of ET in Caucasian subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530959     DOI: 10.1016/j.neulet.2006.02.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Genetic analysis of the leucine-rich repeat and lg domain containing Nogo receptor-interacting protein 1 gene in essential tremor.

Authors:  Hui Liang; Zhi Song; Xiong Deng; Hongbo Xu; Anding Zhu; Wen Zheng; Yongxiang Zhao; Hao Deng
Journal:  J Mol Neurosci       Date:  2013-06-12       Impact factor: 3.444

2.  Anti-Tremor Action of Subtype Selective Positive Allosteric Modulators of GABAA Receptors in a Rat Model of Essential Tremors.

Authors:  Dipak V Amrutkar; Tino Dyhring; Thomas A Jacobsen; Janus S Larsen; Karin Sandager-Nielsen
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

Review 3.  Challenges in essential tremor genetics.

Authors:  L N Clark; E D Louis
Journal:  Rev Neurol (Paris)       Date:  2015-05-21       Impact factor: 2.607

Review 4.  Current Opinions and Consensus for Studying Tremor in Animal Models.

Authors:  Sheng-Han Kuo; Elan D Louis; Phyllis L Faust; Adrian Handforth; Su-Youne Chang; Billur Avlar; Eric J Lang; Ming-Kai Pan; Lauren N Miterko; Amanda M Brown; Roy V Sillitoe; Collin J Anderson; Stefan M Pulst; Martin J Gallagher; Kyle A Lyman; Dane M Chetkovich; Lorraine N Clark; Murni Tio; Eng-King Tan; Rodger J Elble
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

Review 5.  Essential tremor.

Authors:  Lorraine N Clark; Elan D Louis
Journal:  Handb Clin Neurol       Date:  2018

6.  Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor.

Authors:  Arnulfo Quesada; Peter H Bui; Gregg E Homanics; Oliver Hankinson; Adrian Handforth
Journal:  Eur J Pharmacol       Date:  2011-01-21       Impact factor: 4.432

Review 7.  Emerging strategies in the management of essential tremor.

Authors:  Peter Hedera
Journal:  Ther Adv Neurol Disord       Date:  2016-11-30       Impact factor: 6.570

Review 8.  Linking Essential Tremor to the Cerebellum: Neurochemical Evidence.

Authors:  Juan Marin-Lahoz; Alexandre Gironell
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

Review 9.  Environmental epidemiology of essential tremor.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

10.  Evaluation of SCN8A as a candidate gene for autosomal dominant essential tremor.

Authors:  Lisa M Sharkey; Julie M Jones; Peter Hedera; Miriam H Meisler
Journal:  Parkinsonism Relat Disord       Date:  2008-08-20       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.